Dipeptidyl peptidase 4 (DPP-4) inhibitors

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10BG

Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

DPP4INH

Extra metadata

First used in FinnGen datafreeze DF2

↥

List of similar endpoints to Dipeptidyl peptidase 4 (DPP-4) inhibitors based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

↥

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	2.49 [1.80, 3.45]	3.4e-8	293
15 years	0.02	2.51 [1.82, 3.46]	1.7e-8	288
5 years	0.00	2.32 [1.66, 3.24]	8.1e-7	71
1 year	-	-	-	-

↥

Index endpoint: DPP4INH – Dipeptidyl peptidase 4 (DPP-4) inhibitors
GWS hits:

↥

before Dipeptidyl peptidase 4 (DPP-4) inhibitors
after Dipeptidyl peptidase 4 (DPP-4) inhibitors

Loading survival analyses plot

Loading survival analyses table

↥